Cargando…

Virtual opioid agonist treatment: Alberta’s virtual opioid dependency program and outcomes

BACKGROUND: Virtually delivered healthcare (telehealth, telemedicine) has the potential to reduce gaps in access to opioid agonist therapy (OAT). Barriers to accessing OAT such as lack of transportation, in-person induction requirements, employment demands and limited childcare options reduce treatm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Day, Nathaniel, Wass, Maureen, Smith, Kelly
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330968/ https://www.ncbi.nlm.nih.gov/pubmed/35902924 http://dx.doi.org/10.1186/s13722-022-00323-4

Ejemplares similares

The effect of opioid analgesics, benzodiazepines, gabapentinoids, and opioid agonist treatment on mortality risk among opioid-dependent people.
por: Bharat, Chrianna, et al.
Publicado: (2022)

Rescue Analgesia for Opioid-Dependent Individuals on Opioid Agonist Treatment during Hospitalization: Adherence to Guideline Treatment
por: Arnet, Isabelle, et al.
Publicado: (2023)

A Virtual-First Telehealth Treatment Model for Opioid Use Disorder
por: Williams, Arthur Robin, et al.
Publicado: (2022)

Feasibility and acceptability of virtual academic detailing on opioid prescribing
por: Smart, Mary H., et al.
Publicado: (2021)

Prevalence of Opioid Dependence and Opioid Agonist Treatment in the Berlin Custodial Setting: A Cross-Sectional Study
por: von Bernuth, Kira, et al.
Publicado: (2020)

Interim opioid agonist treatment for opioid addiction: a systematic review
por: Samsó Jofra, Laura, et al.
Publicado: (2022)

Alcohol use in opioid agonist treatment
por: Nolan, Seonaid, et al.
Publicado: (2016)

A systematic review of health economic models of opioid agonist therapies in maintenance treatment of non-prescription opioid dependence
por: Chetty, Mersha, et al.
Publicado: (2017)

A focus on the future of opioid prescribing: implementation of a virtual opioid and pain management module for medical students
por: Adalbert, Jenna R., et al.
Publicado: (2022)

Using routinely collected data to understand and predict adverse outcomes in opioid agonist treatment: Protocol for the Opioid Agonist Treatment Safety (OATS) Study
por: Larney, Sarah, et al.
Publicado: (2018)

Biphalin—A Potent Opioid Agonist—As a Panacea for Opioid System-Dependent Pathophysiological Diseases? †
por: Redkiewicz, Patrycja, et al.
Publicado: (2021)

Sex work involvement among women with long-term opioid injection drug dependence who enter opioid agonist treatment
por: Marchand, Kirsten, et al.
Publicado: (2012)

Changing Pattern of Opioid Users Attending an Opioid Agonist Treatment Clinic in North India
por: Bhat, Fazle R., et al.
Publicado: (2022)

What is the benefit of inconsistent opioid agonist treatment in patients with prescription opioid use disorder?
por: Weiss, R., et al.
Publicado: (2023)

Better agonist for the opioid receptors
por: Badshah, Syed Lal, et al.
Publicado: (2018)

Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
por: Soyka, Michael
Publicado: (2021)

Probing the Activation Mechanisms of Agonist DPI-287 to Delta-Opioid Receptor and Novel Agonists Using Ensemble-Based Virtual Screening with Molecular Dynamics Simulations
por: Dean, Emily, et al.
Publicado: (2023)

Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17
por: Yang, Justin C., et al.
Publicado: (2019)

Safety and preliminary outcomes of short-acting opioid agonist treatment (sOAT) for hospitalized patients with opioid use disorder
por: Thakrar, Ashish P., et al.
Publicado: (2023)

State-dependent inhibition of BK channels by the opioid agonist loperamide
por: Vouga, Alexandre G., et al.
Publicado: (2021)

Trends in smoking during pregnancy stratified by the use of opioid agonist therapy and the contribution of smoking to poor outcome in neonates prenatally exposed to opioid agonist treatment
por: Kelty, Erin, et al.
Publicado: (2023)

Ligand-Specific Regulation of the Endogenous Mu-Opioid Receptor by Chronic Treatment with Mu-Opioid Peptide Agonists
por: Murányi, Marianna, et al.
Publicado: (2013)

Opioid induced hypogonadism
por: Reddy, Raghava G, et al.
Publicado: (2010)

Rapid transitional response to the COVID-19 pandemic by opioid agonist treatment programs in Ukraine
por: Meteliuk, Anna, et al.
Publicado: (2021)

Discovery of Novel µ-Opioid Receptor Inverse Agonist from a Combinatorial Library of Tetrapeptides through Structure-Based Virtual Screening
por: Poli, Giulio, et al.
Publicado: (2019)

Therapeutic Potential of Kappa Opioid Agonists
por: Beck, Tyler C., et al.
Publicado: (2019)

Prevalence of COVID-19 outcomes in patients referred to opioid agonist treatment centers
por: Khani, Samira, et al.
Publicado: (2023)

Availability of opioid agonist treatment and critical incidents in Forensic Clinics for Dependency Diseases in Germany
por: Reiners, Sven, et al.
Publicado: (2022)

Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021
por: Rosic, Tea, et al.
Publicado: (2023)

Safe opioid prescribing: a prognostic machine learning approach to predicting 30-day risk after an opioid dispensation in Alberta, Canada
por: Sharma, Vishal, et al.
Publicado: (2021)

Opioid Agonist Therapies and Pregnancy Outcomes for Pregnant People With Opioid Use Disorder: Protocol for a Systematic Review
por: Wilson, Lindsay A, et al.
Publicado: (2023)

Opioid Dependence Treatment and Guidelines
por: Nicholls, Lance, et al.
Publicado: (2010)

The effect of entry and retention in opioid agonist treatment on contact with the criminal justice system among opioid-dependent people: a retrospective cohort study
por: Gisev, Natasa, et al.
Publicado: (2019)

Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors
por: Shen, Qianwei, et al.
Publicado: (2017)

Age differences in heroin and prescription opioid abuse among enrolees into opioid treatment programs
por: Cleland, Charles M, et al.
Publicado: (2011)

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

The Neurobiology of Opioid Dependence: Implications for Treatment
por: Kosten, Thomas R., et al.
Publicado: (2002)

The “black box” of treatment: Patients’ perspective on what works in opioid maintenance treatment for opioid dependence
por: Silva, Teresa C., et al.
Publicado: (2021)

Agonist Treatment for Opioid Dependence Syndrome: The Impact of Current Understanding upon Recommendations for Policy Initiatives
por: Dickson, Cheryl, et al.
Publicado: (2021)

Characterizing the Rural Opioid Use Environment in Kentucky Using Google Earth: Virtual Audit
por: Crawford, Natalie Danielle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_qth0sp41hftq7qfa9g9impjp17